JP2011518811A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518811A5
JP2011518811A5 JP2011505534A JP2011505534A JP2011518811A5 JP 2011518811 A5 JP2011518811 A5 JP 2011518811A5 JP 2011505534 A JP2011505534 A JP 2011505534A JP 2011505534 A JP2011505534 A JP 2011505534A JP 2011518811 A5 JP2011518811 A5 JP 2011518811A5
Authority
JP
Japan
Prior art keywords
compound
formula
pyrazol
methyl
yloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011505534A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011518811A (ja
Filing date
Publication date
Priority claimed from EP08384005A external-priority patent/EP2113501A1/en
Application filed filed Critical
Publication of JP2011518811A publication Critical patent/JP2011518811A/ja
Publication of JP2011518811A5 publication Critical patent/JP2011518811A5/ja
Pending legal-status Critical Current

Links

JP2011505534A 2008-04-25 2009-04-27 シグマ受容体阻害剤として有用な5−メチル−1−(ナフタレン−2−イル)−1h−ピラゾール Pending JP2011518811A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08384005.8 2008-04-25
EP08384005A EP2113501A1 (en) 2008-04-25 2008-04-25 5-Methyl-1-(naphthalen-2-YL)-1H-Pyrazoles useful as sigma receptor inhibitors
PCT/EP2009/055065 WO2009130331A1 (en) 2008-04-25 2009-04-27 5-methyl-1-(naphthalen-2-yl)-1h-pyrazoles useful as sigma receptor inhibitors

Publications (2)

Publication Number Publication Date
JP2011518811A JP2011518811A (ja) 2011-06-30
JP2011518811A5 true JP2011518811A5 (cg-RX-API-DMAC10.html) 2012-06-07

Family

ID=39739580

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011505534A Pending JP2011518811A (ja) 2008-04-25 2009-04-27 シグマ受容体阻害剤として有用な5−メチル−1−(ナフタレン−2−イル)−1h−ピラゾール

Country Status (11)

Country Link
US (1) US8492425B2 (cg-RX-API-DMAC10.html)
EP (2) EP2113501A1 (cg-RX-API-DMAC10.html)
JP (1) JP2011518811A (cg-RX-API-DMAC10.html)
KR (1) KR20110006697A (cg-RX-API-DMAC10.html)
CN (1) CN102066333A (cg-RX-API-DMAC10.html)
AU (1) AU2009239906A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0910679A2 (cg-RX-API-DMAC10.html)
CA (1) CA2722256A1 (cg-RX-API-DMAC10.html)
MX (1) MX2010011674A (cg-RX-API-DMAC10.html)
RU (1) RU2010147918A (cg-RX-API-DMAC10.html)
WO (1) WO2009130331A1 (cg-RX-API-DMAC10.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
DK2503993T3 (en) * 2009-11-25 2016-08-22 Esteve Labor Dr Hydrochloridsalt af 4-[2-[[5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]-morpholin
EP2361904A1 (en) * 2010-02-04 2011-08-31 Laboratorios Del. Dr. Esteve, S.A. 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride and crystalline forms thereof
EP2353598A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for use in the prevention and/or treatment of postoperative pain
SG10201500832PA (en) * 2010-02-04 2015-04-29 Esteve Labor Dr 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
EP2388005A1 (en) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
EP2395003A1 (en) 2010-05-27 2011-12-14 Laboratorios Del. Dr. Esteve, S.A. Pyrazole compounds as sigma receptor inhibitors
EP2418192A1 (en) * 2010-07-30 2012-02-15 Esteve Química, S.A. Intermediates for the preparation of 1-aryl-pyrazol-3-one compounds useful as sigma receptors inhibitors
EP2415471A1 (en) * 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2426111A1 (en) * 2010-08-09 2012-03-07 Laboratorios Del. Dr. Esteve, S.A. 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms
EP2460519A1 (en) * 2010-12-03 2012-06-06 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in bone cancer pain
EP2460804A1 (en) * 2010-12-03 2012-06-06 Laboratorios Del Dr. Esteve, S.A. 5-methyl-1-(naphthalen-2-yl)-1h-pyrazole derivatives and their use in potentiating the effect of opioid analgesics
EP2524694A1 (en) * 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
EP2818166A1 (en) * 2013-06-26 2014-12-31 Laboratorios del Dr. Esteve S.A. Use of sigma receptor ligands for the prevention and treatment of pain associated to interstitial cystitis/bladder pain syndrome (IC/BPS)
SG11201604480PA (en) 2013-12-17 2016-07-28 Esteve Labor Dr SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS
CN107073328A (zh) 2014-08-01 2017-08-18 智能台球照明有限责任公司 台球桌照明与比赛进行监视器
MA41177A (fr) * 2014-12-15 2017-10-24 Esteve Labor Dr Utilisation de ligands des récepteurs sigma dans l'arthrose
WO2023154654A2 (en) 2022-02-09 2023-08-17 Martin Blake Robert Interactive led system for enhancing billiard gameplay

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9824310D0 (en) 1998-11-05 1998-12-30 Univ London Activators of soluble guanylate cyclase
EP1634872A1 (en) * 2004-08-27 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Pyrazole derivatives as sigma receptor inhibitors
KR101352012B1 (ko) 2004-08-27 2014-01-15 라보라토리오스 델 드라. 에스테브.에스.에이. 시그마 수용체 저해제
MX2008011016A (es) 2006-03-01 2008-09-08 Esteve Labor Dr Inhibidores de receptor sigma.
EP1829875A1 (en) * 2006-03-01 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Pyrazole derivatives as sigma receptor inhibitors

Similar Documents

Publication Publication Date Title
JP2011518811A5 (cg-RX-API-DMAC10.html)
RU2010147918A (ru) 5-метил-1-(нафталин-2-ил)-1н-пиразолы в качестве ингибиторов сигма-рецепторов
AU2014219283C1 (en) Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
JP2010513319A5 (cg-RX-API-DMAC10.html)
CN115667238A (zh) 一种五并五元环衍生物及其在医药上的应用
JP2010077141A5 (cg-RX-API-DMAC10.html)
JP2012533546A5 (cg-RX-API-DMAC10.html)
JP2012530765A5 (cg-RX-API-DMAC10.html)
JP2008511683A5 (cg-RX-API-DMAC10.html)
JP2019505541A5 (cg-RX-API-DMAC10.html)
JP2014526500A5 (cg-RX-API-DMAC10.html)
JP2008520742A5 (cg-RX-API-DMAC10.html)
JP2011519854A5 (cg-RX-API-DMAC10.html)
JP2017504595A5 (cg-RX-API-DMAC10.html)
JP2009543795A5 (cg-RX-API-DMAC10.html)
JP2015508092A5 (cg-RX-API-DMAC10.html)
JP2014528464A5 (cg-RX-API-DMAC10.html)
JP2010524899A5 (cg-RX-API-DMAC10.html)
JP2010527985A5 (cg-RX-API-DMAC10.html)
JP2013542267A5 (cg-RX-API-DMAC10.html)
JP2013506674A5 (cg-RX-API-DMAC10.html)
JP2015524483A5 (cg-RX-API-DMAC10.html)
JP2017519796A5 (cg-RX-API-DMAC10.html)
JP2017500321A5 (cg-RX-API-DMAC10.html)
JP2018503647A5 (cg-RX-API-DMAC10.html)